advertisement
30 November 2012

J&J says won't enforce Aids drug patent in Africa

Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson's HIV/AIDS drug Prezista for sale in Africa and other poor countries.

0

Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson's HIV/Aids drug Prezista for sale in Africa and other poor countries.

US healthcare group J&J said it would not enforce patents, provided generic firms made high-quality versions of the drug - known generically as darunavir - for sub-Saharan Africa and Least Developed Countries.

Prezista is a relatively new drug used when patients develop resistance to older antiretrovirals. The need for it was expected to grow rapidly as more patients in Africa stop responding to existing therapies.

Pharmaceuticals head Paul Stoffels said he expected Indian drug-makers, in particular, to take advantage of the patent move, adding that competition among different companies should drive prices down further.

Going direct

J&J has an existing deal with South African group Aspen Pharmacare, which makes Prezista at a discounted price of $2.22 per day for Africa - a fraction of the western market price.

Its decision to act unilaterally on Prezista patents will, however, disappoint those calling for J&J to share intellectual property rights in the new Medicines Patent Pool, which aims to streamline generic production by pooling patents.

"We have chosen to go direct we think that is the best way," Stoffels said in an interview.

"We want to reserve the right to reinforce patents if people are not providing the right quality of product, for example by bringing products to market that under-dose."

International drug-makers are under growing pressure to make medicines more affordable in poor countries, after being attacked for not doing enough in the past.

J&J ranked second in a new analysis of how companies are performing in providing access to medicines - an improvement of seven places from two years earlier, following its purchase of Crucell, which makes vaccines for the developing world.

(Reuters Health, November 2012)

Read More:

Cost of Aids drugs to drop

HIV-prevention drug gets endorsement

Drugs to treat HIV also reduce risk of infection

 

More:

HIV/AidsNews
advertisement

Get a quote

advertisement

Read Health24’s Comments Policy

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining

Live healthier

Strenghten your immunity »

Keep your immunity strong Immune system boosters Boost your family's immunity

5 immune boosters in your kitchen

You don’t need a handful of vitamins and supplements to keep your body healthy, check out these five immune boosting foods you probably already have in your kitchen.

Laugh a little »

Eat yourself happy Laugh more and live longer Laughing yoga the best medicine

The healing power of laughter

A good chuckle doesn't only make you feel happy for a moment, it's beneficial to your health too.